Phase 4 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with intermediate or high risk non-muscle-invasive bladder cancer who have been recommended for a course of BCG treatment given directly into the bladder
- People who have not yet started their BCG treatment course
- People who are able to lie flat on their back (with up to two pillows under their head if needed) for two hours
- People who are able to sit upright for two hours
- People who are willing to wear a fitness tracking device for at least five days during the study
- People who are able to attend appointments by video call or phone
- People who are able to give their own informed consent to participate
Who may not be able to join:
- People who have received BCG treatment directly into the bladder within the past year
- People who are known to be unable to hold BCG fluid inside the bladder
- People who have a history of bladder control problems, specifically those who score 3 or higher on a standard bladder urgency and leakage questionnaire called the Overactive Bladder Survey
- People who are unwilling to wear a fitness tracker during a 24-hour baseline period, during treatment sessions, and/or for 2 hours after each treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cheryl T Lee, MD, Ohio State University Comprehensive Cancer Center
Phone: 800-293-5066
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Bacillus Calmette Guerin (BCG) dwell time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.